[Prolonged administration of hydralazine in the guinea pig. Serologic and clinico-pathologic changes].
D000818:Animals; D000888:Antibodies, Anti-Idiotypic; D000917:Antibody Formation; D002467:Cell Nucleus / Q000276:immunology; D004285:Dogs; D005260:Female; D005455:Fluorescent Antibody Technique; D006168:Guinea Pigs; D006644:Histiocytes; D006830:Hydralazine / Q000008:administration & dosage / Q000494:pharmacology*; D006973:Hypertension / Q000188:drug therapy; D008168:Lung / Q000473:pathology; D008180:Lupus Erythematosus, Systemic; D008214:Lymphocytes; D008297:Male; D009504:Neutrophils; D010950:Plasma Cells; D051381:Rats; D014352:Trypanosomiasis / Q000276:immunology
D000888:Antibodies, Anti-Idiotypic; D006830:Hydralazine
Administration prolongée d'hydralazine chez le cobaye. Bilan sérologique et clinicopathologique.